Home
Conditions
Breast Neoplasms, Male

Clinical trial condition

Breast Neoplasms, Male

Explore clinical trials studying Breast Neoplasms, Male. Study availability and eligibility vary by location and protocol.

213 public trials 6 recruiting studies

Refine in advanced search Browse all conditions

Breast Neoplasms, Male trial results

Completed

ONTAK® in Treating Patients With Advanced Breast Cancer That Did Not Respond to Previous Treatment

NCT00425672

Conditions: Breast Diseases, Breast Neoplasms, Breast Neoplasms, Male, +10 more
Locations: Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States

View Trial Details

Completed

Treating Patients With Advanced Solid Tumors, Breast Cancer or Recurrent Ovarian Cancer

NCT00005807

Conditions: Adnexal Diseases, Breast Cancer, Breast Diseases, +24 more
Locations: NYU School of Medicine's Kaplan Comprehensive Cancer Center New York, United States

Albert Einstein Clinical Cancer Center The Bronx, New York, United States

View Trial Details

Completed

Vaccine Therapy in Treating Patients With Previously Treated Stage II-III HER2-Positive Breast Cancer

NCT01632332

Conditions: Breast Diseases, Breast Neoplasms, Breast Neoplasms, Male, +10 more
Locations: Mayo Clinic Rochester, Minnesota, United States

View Trial Details

Completed

Trastuzumab, Cyclophosphamide, and Vaccine Therapy in Treating Patients With High-Risk or Metastatic Breast Cancer

NCT00847171

Conditions: Breast Cancer, Breast Diseases, Breast Neoplasms, +5 more
Locations: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States

View Trial Details

Completed

Tamoxifen +/- GnRH Analogue vs Aromatase Inhibitor + GnRH Analogue in Male Breast Cancer Patients

NCT01638247

Conditions: Breast Diseases, Breast Neoplasms, Breast Neoplasms, Male, +5 more
Locations: Kliniken Essen-Mitte Essen, North Rhine-Westphalia, Germany

View Trial Details

Completed

Nab-paclitaxel (Abraxane) With or Without Mifepristone in Patients With Advanced Breast Cancer

NCT01493310

Conditions: Breast Diseases, Breast Neoplasms, Breast Neoplasms, Male, +10 more
Locations: University of Chicago Chicago, Illinois, United States

NorthShore University Health System Evanston, Illinois, United States

View Trial Details

Completed

Carboplatin, Gemcitabine Hydrochloride, and Mifepristone in Treating Patients With Advanced Breast Cancer or Recurrent or Persistent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer

NCT02046421

Conditions: Adnexal Diseases, Breast Diseases, Breast Neoplasms, +31 more
Locations: University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States

NorthShore University HealthSystem Evanston, Illinois, United States

View Trial Details

Completed

Ganetespib, Paclitaxel, Trastuzumab and Pertuzumab for Metastatic Human Epidermal Growth Factor Receptor 2 Positive Breast Cancer

NCT02060253

Conditions: Breast Diseases, Breast Neoplasms, Breast Neoplasms, Male, +11 more
Locations: NYU Cancer Institute New York, United States

Memorial Sloan-Kettering Cancer Center New York, United States

View Trial Details

Completed

Cixutumumab and Temsirolimus in Treating Patients With Locally Recurrent or Metastatic Breast Cancer

NCT00699491

Conditions: Breast Diseases, Breast Neoplasms, Breast Neoplasms, Male, +7 more
Locations: Palo Alto Medical Foundation Health Care Palo Alto, California, United States

Valley Medical Oncology Consultants Pleasanton, California, United States

The Medical Center of Aurora Aurora, Colorado, United States

Boulder Community Hospital Boulder, Colorado, United States

View all 192 locations

View Trial Details

Completed

FLT PET in Measuring Treatment Response in Patients With Newly Diagnosed Estrogen Receptor-Positive, HER2-Negative Stage I-III Breast Cancer

NCT01928186

Conditions: Breast Diseases, Breast Neoplasms, Breast Neoplasms, Male, +14 more
Locations: Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States

View Trial Details

Breast Neoplasms, Male

Breast Neoplasms, Male trial results

Related conditions